Infinity Pharmaceuticals | INFI - DEBITO





DEBITO Cambiamento Data
AbbVie USD 67.5B 67.5B 2025-12
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 54.6B 17M 2025-12
AstraZeneca USD 33.92B 4.3B 2026-03
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Gilead Sciences USD 24.94B 5M 2025-12
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Grifols EUR 9.23B 626.05M 2024-12
Incyte USD 39.43M 982K 2026-03
Infinity Pharmaceuticals USD 0 0 2022-06
Ionis Pharmaceuticals USD 2.34B 9.5M 2026-03
J&J USD 47.93B 2.14B 2025-12
Novartis USD 47B 11.62B 2026-03
Pfizer USD 63.73B 231M 2026-03
Plus Therapeutics USD 3.98M 372K 2023-12
Roche Holding CHF 33.03B 1.41B 2025-06
TG Therapeutics USD 253.71M 8.37M 2025-12